CLINICAL_TRIALS
ClinicalTrials.gov record update
Managed Access Programs for PKC412, Midostaurin
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05219266
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:25.080373+00:00
- Published At
- 2024-06-28T00:00:00+00:00
- Record Updated At
- 2024-06-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia", "Acute Myeloid Leukemia", "Aggressive Systemic Mastocytosis", "Mast Cell Leukemia", "Systemic Mastocytosis With an Associated Hematologic Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-06-28"- protocolSection.identificationModule.nctId
"NCT05219266"- protocolSection.identificationModule.officialTitle
"Managed Access Programs for PKC412, Midostaurin"- protocolSection.statusModule.overallStatus
"NO_LONGER_AVAILABLE"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.